En | De
Sie sind hier: Onkologie 14. August 2020
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Endokrine Organe
Gynäkologische Tumoren
Urologische Tumoren
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 68641  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 1372808  
Hypoxia-mediated cancer stem cell resistance and targeted therapy.
Biomed Pharmacother
Sun X, Lv X, Yan Y, Zhao Y, Ma R, He M, Wei M.
PMID: 32791395 [PubMed - as supplied by publisher]

Traditional Chinese exercise for cancer-related sleep disturbance: A systematic review and descriptive analysis of randomized controlled trials.
Complement Ther Clin Pract
Yao LQ, Tan JY, Turner C, Wang T, Liu XL.
PMID: 32791319 [PubMed - as supplied by publisher]

The remaining ipsilateral ureteral orifice provokes intravesical tumor recurrence after nephroureterectomy for upper tract urothelial carcinoma: A multicenter study with a mid-term follow-up.
Kwon SY, Ko YH, Song PH, Kim BH, Kim BS, Kim TH, KYUS group..
PMID: 32791287 [PubMed - as supplied by publisher]

Lipids in the tumor microenvironment: From cancer progression to treatment.
Prog Lipid Res
Corn KC, Windham MA, Rafat M.
PMID: 32791170 [PubMed - as supplied by publisher]

Mechanisms of cancer stem cell therapy.
Clin Chim Acta
Akbar Samadani A, Keymoradzdeh A, Shams S, Soleymanpour A, Elham Norollahi S, Vahidi S, Rashidy-Pour A, Ashraf A, Mirzajani E, Khanaki K, Rahbar Taramsari M, Samimian S, Najafzadeh A.
PMID: 32791136 [PubMed - as supplied by publisher]

Association between Hydrochlorothiazide and the Risk of In-situ and Invasive Squamous Cell Skin Carcinoma and Basal Cell Carcinoma: A Population-Based Case-Control Study.
J Am Acad Dermatol
Adalsteinsson JA, Muzumdar S, Waldman R, Hu C, Wu R, Ratner D, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson J.
PMID: 32791082 [PubMed - as supplied by publisher]

CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies.
Lancet Haematol
Rust BJ, Kiem HP, Uldrick TS.
PMID: 32791043 [PubMed - as supplied by publisher]

Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT.
Cancer Biol Ther
Handy WF, Schmidt KT, Price DK, Figg WD.
PMID: 32791030 [PubMed - as supplied by publisher]

The Impact of a Ketogenic Dietary Intervention on the Quality of Life of Stage II and III Cancer Patients: A Randomized Controlled Trial in the Caribbean.
Nutr Cancer
Augustus E, Granderson I, Rocke KD.
PMID: 32791011 [PubMed - as supplied by publisher]

Novel insights into the function of CD24: a driving force in cancer.
Int J Cancer
Altevogt P, Sammar M, Hüser L, Kristiansen G.
PMID: 32790899 [PubMed - as supplied by publisher]

Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.
PLoS One
Fukuda H, Sato D, Moriwaki K, Ishida H.
PMID: 32790706 [PubMed - as supplied by publisher]

Mutations in m6A consensus motifs are suppressed in the m6A modified genes in human cancer cells.
PLoS One
An M, Wang H, Zhu Y.
PMID: 32790688 [PubMed - as supplied by publisher]

Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction.
PLoS One
Vijayasarveswari V, Andrew AM, Jusoh M, Sabapathy T, Raof RAA, Yasin MNM, Ahmad RB, Khatun S, Rahim HA.
PMID: 32790672 [PubMed - as supplied by publisher]

Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
Acta Oncol
Hermunen K, Soveri LM, Boisen MK, Mustonen HK, Dehlendorff C, Haglund CH, Johansen JS, Osterlund P.
PMID: 32790589 [PubMed - as supplied by publisher]

MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review.
J Int Med Res
Wei XY, Ding J, Tian WG, Yu YC.
PMID: 32790532 [PubMed - as supplied by publisher]

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.
J Clin Oncol
Tew WP, Lacchetti C, Ellis A, Maxian K, Banerjee S, Bookman M, Jones MB, Lee JM, Lheureux S, Liu JF, Moore KN, Muller C, Rodriguez P, Walsh C, Westin SN, Kohn EC.
PMID: 32790492 [PubMed - as supplied by publisher]

Engineering Nanoparticles toward the Modulation of Emerging Cancer Immunotherapy.
Adv Healthc Mater
Wang S, Sun Z, Hou Y.
PMID: 32790039 [PubMed - as supplied by publisher]

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer.
Garje R, An J, Obeidat M, Kumar K, Yasin HA, Zakharia Y.
PMID: 32790011 [PubMed - as supplied by publisher]

Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
Int J Urol
Tomita Y, Tatsugami K, Nakaigawa N, Osawa T, Oya M, Kanayama H, Nakayama Kondoh C, Sassa N, Nishimura K, Nozawa M, Masumori N, Miyoshi Y, Kuroda S, Tanaka S, Kimura A, Tamada S.
PMID: 32789967 [PubMed - as supplied by publisher]

Metastatic breast cancer diagnosed on cervical cytology.
Yuan L, Oshilaja O, Sierk A, Zhang G, Booth CN, Brainard J, Dyhdalo KS.
PMID: 32789952 [PubMed - as supplied by publisher]

   Artikel 1 - 20 / 1372808    Seite 1 von 68641  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.



mehr >>


Sky right 1